Changes

no edit summary
Line 1,671: Line 1,671:  
|
 
|
 
|-
 
|-
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''||
+
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''||Peining Li, PhD
|
   
|
 
|
 
|
 
|
 +
|PENDING
 
| ||SP
 
| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
|    Lymphomatoid  Papulosis||Disease||
+
|    Lymphomatoid  Papulosis||Disease||Peining Li, PhD
|
   
|
 
|
 
|
 
|
 +
|PENDING
 
| ||SP
 
| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
|    Primary Cutaneous Anaplastic Large Cell Lymphoma||Disease||Theresa Spivey, MD, Shashirekha Shetty, PhD
+
|    Primary Cutaneous Anaplastic Large Cell Lymphoma||Disease||Theresa Spivey, MD, Shashirekha Shetty, PhD
 
|
 
|
 
|
 
|
Line 1,695: Line 1,695:  
|
 
|
 
|-
 
|-
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''||
+
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''||Peining Li, PhD
|
   
|
 
|
 
|
 
|
 +
|PENDING
 
| ||SP
 
| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
|     Primary Cutaneous Gamma Delta T-cell Lymphoma||Disease||
+
|     Primary Cutaneous Gamma Delta T-cell Lymphoma||Disease||Peining Li, PhD
|
   
|
 
|
 
|
 
|
 +
|PENDING
 
| ||SP
 
| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
|     Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease||
+
|     Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease||Peining Li, PhD
|
   
|
 
|
 
|
 
|
 +
|PENDING
 
| ||SP
 
| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
|     Primary Cutaneous Acral CD8+ T-cell Lymphoma||Disease||
+
|     Primary Cutaneous Acral CD8+ T-cell Lymphoma||Disease||Peining Li, PhD
|
   
|
 
|
 
|
 
|
 +
|PENDING
 
| ||SP
 
| ||SP
 
|
 
|
 
|
 
|
 
|-
 
|-
|     Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease||
+
|     Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease||Peining Li, PhD
|
   
|
 
|
 
|
 
|
 +
|PENDING
 
| ||SP
 
| ||SP
 
|
 
|